Flare up of symptoms after discontinuation of sunitinib in patient with lung cancer

MeSH terms

• Adenocarcinoma / pathology*
• Adenocarcinoma / therapy
• Adenocarcinoma of Lung
• Administration, Oral
• Antineoplastic Agents / administration & dosage*
• Antineoplastic Agents / adverse effects
• Combined Modality Therapy
• Disease Progression
• Female
• Humans
• Indoles / administration & dosage*
• Lung Neoplasms / pathology*
• Lung Neoplasms / therapy
• Middle Aged
• Neoplasm Metastasis
• Pyrroles / administration & dosage*
• Sunitinib
• Treatment Outcome
• Withholding Treatment